Navigation Links
Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
Date:8/30/2011

ALLEGAN, Mich., Aug. 30, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Ketoconazole Foam, 2%, the generic version of Extina® Ketoconazole Foam, 2%. Perrigo has commenced shipping of the product and was first to file, enabling 180 days of marketing exclusivity. This product is part of the Perrigo/Cobrek collaboration.

Extina® Ketoconazole Foam, 2% has annual retail sales of approximately $10 million dollars. This product is indicated for topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older.

Perrigo's Chairman and CEO Joseph C. Papa concluded, "This launch reflects our continuing investment in new products. It is an example of the excellent partnership we have with Cobrek for developing foam products which is a key product category for our Rx business. Perrigo is committed to making quality healthcare more affordable for our customers and drive value for our shareholders."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is the world's largest store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Perrigo Company Will Release Fourth Quarter Fiscal 2011 Results on August 16, 2011
2. Watson Enters into Agreement to Acquire Products Related to Perrigos Acquisition of Paddock Laboratories
3. Perrigo Closes Acquisition of Paddock Labs
4. Perrigo Receives FDA Approval to Market Coated Cinnamon Nicotine Gum
5. Perrigo Provides Update on Acquisition of Paddock Labs
6. Perrigo Announces Launch of the Generic Version of Nasacort® AQ
7. Perrigo Company to Present at the Goldman Sachs 32nd Annual Global Health Care Conference
8. Perrigos Partner Synthon Receives FDA Tentative Approval for Levocetirizine Solution - Generic Equivalent to Xyzal® Oral Solution
9. Perrigo Announces FDA Final Approval for Ranitidine 150 - Generic Equivalent to Zantac 150®
10. Perrigo Announces Settlement of Cutivate Lotion Litigation
11. Perrigo to Introduce New Dosing System and Labeling for Certain Pediatric Pain Relievers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014  CVS Caremark (NYSE: CVS ... clinical affiliation with MedStar Health, a leading health care ... and the Washington, DC , ... care services for patients. Through this clinical affiliation, MedStar ... support, medication counseling, chronic disease monitoring and wellness programs ...
(Date:8/27/2014)... ON , Aug. 27, 2014 /CNW/ - Covalon Technologies ... technologies company, announces the following financial results for its third ... ended June 30, 2014: , Revenue of $1,291,378, ... year , Net loss for the quarter of $240,156 ... of the prior year For the nine ...
(Date:8/27/2014)... Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... H. Mackaness is scheduled to make an investor presentation ... 2:55 p.m. Eastern Time on Wednesday, September 3, in New ... the investor presentation will be available in the Investors section ... About IRIDEX IRIDEX Corporation was founded in ...
Breaking Medicine Technology:CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical ... President and Chief Executive Officer (CEO).  Thomas Beck, M.D., ... resume his role as Chief Medical Officer of the ... cream, is concluding Phase 3 clinical trials to support ...
... N.C., Nov. 17, 2010 Patients with Chronic Obstructive ... disease as both a burden they must deal with ... recent in-home research conducted by GlaxoSmithKline.  Patients participating in ... combination of factors including loss of energy, loss of ...
Cached Medicine Technology:Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer 2Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer 3COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1) 2COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1) 3
(Date:8/27/2014)... 27, 2014 China’s regulatory framework ... of dramatic changes. The country’s new leaders have ... of medical equipment are far from being alongside ... past 30 years. Chinese state council issued the ... Medical Devices” to try to completely change such ...
(Date:8/27/2014)... Toronto, Ontario (PRWEB) August 27, 2014 When ... getting a call from his mother; one that he credits ... ever received. His mom had news that she could set ... camp supporting people with disabilities. Jagger took that job, and ... the disabled. Throughout these past two decades, he also worked ...
(Date:8/27/2014)... Aug. 27, 2014 (HealthDay News) -- A new study ... effective treatment for seniors with sleep apnea. CPAP ... sleep apnea, a condition in which the airway relaxes ... sleep that leads to daytime drowsiness. ... of air through a patient,s nose via a mask ...
(Date:8/27/2014)... parents shapes many aspects of our lives. But in ... is set during development, but can be altered by ... of our parents and grandparents. , The epigenome consists ... that determine whether genes are expressed or silenced. , ... health, but also that it may be possible to ...
(Date:8/27/2014)... Tejal K. Gandhi, MD, MPH, CPPS, president ... the NPSF Lucian Leape Institute, is among the 100 Most ... of Modern Healthcare magazine. Also on the list are NPSF ... MBA; NPSF Lucian Leape Institute members Carolyn Clancy, MD; ... member of both the Institute and the NPSF Board of ...
Breaking Medicine News(10 mins):Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 2Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 3Health News:Scientists map the 'editing marks' on fly, worm, human genomes 4Health News:NPSF President Among 100 Most Influential in Health Care 2Health News:NPSF President Among 100 Most Influential in Health Care 3
... BMR, TORONTO, March 12 /PRNewswire-FirstCall/ - ... in the development and,commercialization of cancer therapies, ... year operational and financial results., Operational ... 31, 2007, the Company achieved the,following steps ...
... INDIANAPOLIS and LONDON, March 12 Today Eli,Lilly ... to the World,Health Organization (WHO) for scaling up ... (MDR-TB) programs., The grant covers four activities, ... to developing countries that the Global,Fund to Fight ...
... Rosa and Santa Rosa Memorial, Hospital to ... make Memorial responsive to its workforce ... In the wake of,news about Sonoma County,s healthcare ... already engaged in a multi-year effort,to win an effective ...
... Brazil, March 11 Amilpar,(BOVESPA: AMIL3, Bloomberg: AMIL3 ... in Brazil, announced today its consolidated,results for the ... The Company,s,operational and financial information is presented on ... with Brazilian Corporate Law and the,Accounts Chart of ...
... blood test that would show whether an antidepressant is ... say they,ve discovered a biomarker for depression that could ... a particular antidepressant is making headway against the disease. ... for depression," said study co-author Mark Rasenick, director of ...
... Speaks on Behalf of People with ... Diabetes During Congressional Briefing, WASHINGTON, March 11 ... of Congress to support,a bill that will develop a national ... was joined today at a briefing on Capitol,Hill by a ...
Cached Medicine News:Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 2Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 3Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 4Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 5Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 6Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 7Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 8Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 9Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 10Health News:Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion 2Health News:Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion 3Health News:Santa Rosa Healthcare Workers Seek Accountability From Catholic Hospital System 2Health News:Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007 2Health News:Scientists Spot Biochemical Sign of Depression 2Health News:Scientists Spot Biochemical Sign of Depression 3Health News:Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator 2Health News:Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator 3
... Medical Delta valve is designed to ... and maintain intraventricular pressure (IVP) within ... patient position. The normally closed Delta ... positive ventricular pressure. Working with the ...
... is an adjustable flow control valve in ... can be changed non-invasively by the caregiver. ... cerebrospinal fluid (CSF) and maintain intraventricular pressure ... of patient position. The normally closed Delta ...
...
... try Cadwell paired disc electrodes. They combine ... contacts are 10 mm (0.4 in) in ... steel with a locator pin on the ... and available in twisted pairs. Shielded paired ...
Medicine Products: